Zobrazeno 1 - 10
of 217
pro vyhledávání: '"Steven J, Feigenberg"'
Autor:
Elizabeth M. Nichols, MD, Søren M. Bentzen, PhD, DMSc, Meghan Milburn, MD, Susan B. Kesmodel, MD, Emily Bellavance, MD, Stewart J. Becker, PhD, Yildirim Mutaf, PhD, Katherine Tkaczuk, MD, Paula Rosenblatt, MD, Steven J. Feigenberg, MD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 4, Pp 101398- (2024)
Purpose: Radiation therapy for early-stage breast cancer is typically delivered in a hypofractionated regimen to the whole breast followed by a tumor bed boost. This results in a treatment course of approximately 4 weeks. In this study, the tumor bed
Externí odkaz:
https://doaj.org/article/50fe9a9c86cb43b99a16b238bcc10c97
Handbook of Breast Cancer and related Breast Disease is a practical guide to the management of patients with breast malignancies and related non-neoplastic lesions. Written and edited by leading experts, this handbook focuses on the application of co
Autor:
Nikhil Yegya-Raman, Timothy P. Kegelman, Sang Ho Lee, Michael J. Kallan, Kristine N. Kim, Jyotsna Natarajan, Matthew P. Deek, Wei Zou, Shannon E. O'Reilly, Zheng Zhang, William Levin, Keith Cengel, Gary Kao, Roger B. Cohen, Lova L. Sun, Corey J. Langer, Charu Aggarwal, Aditi P. Singh, Rupal O'Quinn, Bonnie Ky, Aditya Apte, Joseph Deasy, Ying Xiao, Abigail T. Berman, Salma K. Jabbour, Steven J. Feigenberg
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 39, Iss , Pp 100581- (2023)
Background and purpose: Prior studies have examined associations of cardiovascular substructure dose with overall survival (OS) or cardiac events after chemoradiotherapy (CRT) for non-small cell lung cancer (NSCLC). Herein, we investigate an alternat
Externí odkaz:
https://doaj.org/article/2c6ebd01b13d4332921dd0185ea6507f
Autor:
Wendy B. Harris, PhD, Wei Zou, PhD, Chingyun Cheng, PhD, Varsha Jain, MD, PhD, Boon-Keng Kevin Teo, PhD, Lei Dong, PhD, Steven J. Feigenberg, MD, Abigail T. Berman, MD, MSCE, William P. Levin, MD, Keith A. Cengel, MD, PhD, Shannon E. O’Reilly, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 943-950 (2020)
Purpose: The dosimetric parameters used clinically to reduce the likelihood of radiation pneumonitis (RP) for lung cancer radiation therapy have traditionally been V20Gy ≤ 30% to 35% and mean lung dose ≤ 20 to 23 Gy; however, these parameters are
Externí odkaz:
https://doaj.org/article/f76d306debd74e3b852004b3a2f72ff0
Publikováno v:
Current Oncology Reports. 25:433-444
Autor:
Melissa A.L. Vyfhuis, MD PhD, Neha Bhooshan, MD PhD, Whitney M. Burrows, MD, Michelle Turner, NP, Mohan Suntharalingam, MD MBA, James Donahue, MD, Elizabeth M. Nichols, MD, Josephine Feliciano, MD, Søren M. Bentzen, PhD DMSc, Shahed Badiyan, MD, Shamus R. Carr, MD, Joseph Friedberg, MD, Charles B. Simone, II, MD, Martin J. Edelman, MD, Steven J. Feigenberg, MD, Pranshu Mohindra, MD
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 3, Pp 259-269 (2017)
Purpose: Guidelines for locally advanced non-small cell lung cancer (LA-NSCLC) recommend definitive chemoradiation therapy (CRT) for cN2-N3 disease, reserving surgery for patients with minimal nodal involvement at presentation. The current literature
Externí odkaz:
https://doaj.org/article/034cf0c96c374203aa5b7ace9eafba67
Autor:
Charles B. Simone, Nikhil Yegya-Raman, Shwetha Manjunath, Vivek Verma, Jacob E. Shabason, Lee Xu, Keith A. Cengel, William P. Levin, Abigail T. Berman, John P. Christodouleas, Charu Aggarwal, Roger B. Cohen, Corey J. Langer, Taine T. Pechet, Sunil Singal, John C. Kucharczuk, Ramesh Rengan, Steven J. Feigenberg
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Autor:
Nikhil Yegya-Raman, Cole Friedes, Lova Sun, Michelle Iocolano, Kristine N. Kim, Abigail Doucette, Roger B. Cohen, Kyle W. Robinson, William P. Levin, Keith A. Cengel, Brian Lally, Manuj Agarwal, Christopher A. D'Avella, Melina E. Marmarelis, John A. Kosteva, Aditi P. Singh, Christine A. Ciunci, Charu Aggarwal, Abigail T. Berman, Corey J. Langer, Steven J. Feigenberg
Publikováno v:
Clinical Lung Cancer.
Autor:
Gary D. Kao, Charles B. Simone, Jay F. Dorsey, Stephen M. Hahn, Keith A. Cengel, William Levin, Abigail Berman, Sam Swisher-McClure, Chimbu Chinniah, Amberly Mendes, Louise A. Aguarin, Samuel R. Jean-Baptiste, Steven J. Feigenberg, Melissa A. Frick
Purpose:Although stereotactic body radiotherapy (SBRT) is effective in early-stage non–small cell lung cancer (NSCLC), approximately 10%–15% of patients will fail regionally and 20%–25% distantly. We evaluate a novel circulating tumor cell (CTC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a4e6c41dbeb32a4becc93696d615ee5
https://doi.org/10.1158/1078-0432.c.6529122.v1
https://doi.org/10.1158/1078-0432.c.6529122.v1
Autor:
Gary D. Kao, Charles B. Simone, Jay F. Dorsey, Stephen M. Hahn, Keith A. Cengel, William Levin, Abigail Berman, Sam Swisher-McClure, Chimbu Chinniah, Amberly Mendes, Louise A. Aguarin, Samuel R. Jean-Baptiste, Steven J. Feigenberg, Melissa A. Frick
Supplementary Tables and Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a35317e02cb5dc1bdb97de2c62a5443a
https://doi.org/10.1158/1078-0432.22475607
https://doi.org/10.1158/1078-0432.22475607